Tardive dyskinesia is a type of neurological disorder, which characterized the blink your eyes fast, chew, smack or pucker of lips, puff out your cheeks, tongue and others. The patients treating with neuroleptic drugs or anti-psychotic medications can also be the cause of tardive dyskinesia. Tardive dyskinesia is difficult to treat as treatment process is also not confirmed and the drug is also not approved in various conditions. The treatment of tardive dyskinesia is directly affect the neurological system of the respective patients. This disorder may commonly occurs in smoker than non-smoker, and also in the patient of depression, anxiety disorder and others.
This report aims to provide a comprehensive presentation of the global market for Tardive Dyskinesia (TD) Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tardive Dyskinesia (TD) Treatment Drugs. This report contains market size and forecasts of Tardive Dyskinesia (TD) Treatment Drugs in global, including the following market information:
Global Tardive Dyskinesia (TD) Treatment Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Tardive Dyskinesia (TD) Treatment Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Valbenazine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Tardive Dyskinesia (TD) Treatment Drugs include Neurocrine Biosciences, Inc., Teva Pharmaceutical Industries, Pfizer Inc., Biogen, Novartis AG, AstraZeneca, GlaxoSmithKline plc., Bayer AG and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tardive Dyskinesia (TD) Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tardive Dyskinesia (TD) Treatment Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Tardive Dyskinesia (TD) Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Valbenazine
Deutetrabenazine
Global Tardive Dyskinesia (TD) Treatment Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Tardive Dyskinesia (TD) Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinic
Others
Global Tardive Dyskinesia (TD) Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Tardive Dyskinesia (TD) Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tardive Dyskinesia (TD) Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Tardive Dyskinesia (TD) Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Neurocrine Biosciences, Inc.
Teva Pharmaceutical Industries
Pfizer Inc.
Biogen
Novartis AG
AstraZeneca
GlaxoSmithKline plc.
Bayer AG
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tardive Dyskinesia (TD) Treatment Drugs, market overview.
Chapter 2: Global Tardive Dyskinesia (TD) Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Tardive Dyskinesia (TD) Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tardive Dyskinesia (TD) Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Tardive Dyskinesia (TD) Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tardive Dyskinesia (TD) Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tardive Dyskinesia (TD) Treatment Drugs Overall Market Size
2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size: 2022 VS 2029
2.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tardive Dyskinesia (TD) Treatment Drugs Players in Global Market
3.2 Top Global Tardive Dyskinesia (TD) Treatment Drugs Companies Ranked by Revenue
3.3 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Tardive Dyskinesia (TD) Treatment Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Tardive Dyskinesia (TD) Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tardive Dyskinesia (TD) Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Tardive Dyskinesia (TD) Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Tardive Dyskinesia (TD) Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Markets, 2022 & 2029
4.1.2 Valbenazine
4.1.3 Deutetrabenazine
4.2 By Type - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2018-2023
4.2.2 By Type - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2024-2029
4.2.3 By Type - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2018-2023
5.2.2 By Application - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2024-2029
5.2.3 By Application - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2022 & 2029
6.2 By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2018-2023
6.2.2 By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2024-2029
6.2.3 By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2018-2029
6.3.2 US Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.3.3 Canada Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.3.4 Mexico Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2018-2029
6.4.2 Germany Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.4.3 France Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.4.4 U.K. Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.4.5 Italy Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.4.6 Russia Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.4.8 Benelux Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2018-2029
6.5.2 China Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.5.3 Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.5.4 South Korea Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.5.6 India Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2018-2029
6.6.2 Brazil Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.6.3 Argentina Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2018-2029
6.7.2 Turkey Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.7.3 Israel Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
6.7.5 UAE Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2018-2029
7 Tardive Dyskinesia (TD) Treatment Drugs Companies Profiles
7.1 Neurocrine Biosciences, Inc.
7.1.1 Neurocrine Biosciences, Inc. Company Summary
7.1.2 Neurocrine Biosciences, Inc. Business Overview
7.1.3 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.1.4 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2018-2023)
7.1.5 Neurocrine Biosciences, Inc. Key News & Latest Developments
7.2 Teva Pharmaceutical Industries
7.2.1 Teva Pharmaceutical Industries Company Summary
7.2.2 Teva Pharmaceutical Industries Business Overview
7.2.3 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.2.4 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2018-2023)
7.2.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Company Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.3.4 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2018-2023)
7.3.5 Pfizer Inc. Key News & Latest Developments
7.4 Biogen
7.4.1 Biogen Company Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.4.4 Biogen Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2018-2023)
7.4.5 Biogen Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.5.4 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2018-2023)
7.5.5 Novartis AG Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.6.4 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 GlaxoSmithKline plc.
7.7.1 GlaxoSmithKline plc. Company Summary
7.7.2 GlaxoSmithKline plc. Business Overview
7.7.3 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.7.4 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2018-2023)
7.7.5 GlaxoSmithKline plc. Key News & Latest Developments
7.8 Bayer AG
7.8.1 Bayer AG Company Summary
7.8.2 Bayer AG Business Overview
7.8.3 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.8.4 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2018-2023)
7.8.5 Bayer AG Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.9.4 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Tardive Dyskinesia (TD) Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Tardive Dyskinesia (TD) Treatment Drugs Market Drivers in Global Market
Table 3. Tardive Dyskinesia (TD) Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Tardive Dyskinesia (TD) Treatment Drugs in Global Market
Table 5. Top Tardive Dyskinesia (TD) Treatment Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Tardive Dyskinesia (TD) Treatment Drugs Product Type
Table 9. List of Global Tier 1 Tardive Dyskinesia (TD) Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tardive Dyskinesia (TD) Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Neurocrine Biosciences, Inc. Company Summary
Table 31. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 32. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Neurocrine Biosciences, Inc. Key News & Latest Developments
Table 34. Teva Pharmaceutical Industries Company Summary
Table 35. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 36. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Pharmaceutical Industries Key News & Latest Developments
Table 38. Pfizer Inc. Company Summary
Table 39. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 40. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Inc. Key News & Latest Developments
Table 42. Biogen Company Summary
Table 43. Biogen Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 44. Biogen Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Biogen Key News & Latest Developments
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 48. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis AG Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 52. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. GlaxoSmithKline plc. Company Summary
Table 55. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 56. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. GlaxoSmithKline plc. Key News & Latest Developments
Table 58. Bayer AG Company Summary
Table 59. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 60. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Bayer AG Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 64. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Sanofi Key News & Latest Developments
List of Figures
Figure 1. Tardive Dyskinesia (TD) Treatment Drugs Segment by Type in 2022
Figure 2. Tardive Dyskinesia (TD) Treatment Drugs Segment by Application in 2022
Figure 3. Global Tardive Dyskinesia (TD) Treatment Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tardive Dyskinesia (TD) Treatment Drugs Revenue in 2022
Figure 8. By Type - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2018-2029
Figure 16. US Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2018-2029
Figure 28. China Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Biogen Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
